Kolinpharma S.p.A.

BIT:KIP Stok Raporu

Piyasa değeri: €15.9m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Kolinpharma Yönetim

Yönetim kriter kontrolleri 1/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Rita Petrelli

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresino data
CEO sahipliğin/a
Yönetim ortalama görev süresiVeri yok
Yönetim Kurulu ortalama görev süresi3.8yrs

Son yönetim güncellemeleri

Recent updates

Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

Jun 17
Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Dec 01
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

Aug 25
An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued

We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Jun 08
We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt

Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

May 21
Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?

Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

May 03
Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?

Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

Apr 13
Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio

What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Feb 20
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?

Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Dec 28
Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

Nov 22
These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well

CEO

Rita Petrelli

no data

Görev süresi

Dr. Rita Paola Petrelli is the Co-Founder, Chairwoman of The Board, Chief Executive Officer and Chief Financial Officer of Kolinpharma S.p.A. Dr. Petrelli is chartered accountant, auditor and technical-leg...

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Rita Petrelli
Co-Founderno dataVeri yokVeri yok
Massimo Mantella
CEO & Director4.4yrsVeri yokVeri yok
Francesco Spano
Independent Directorno dataVeri yokVeri yok
Pierluigi Pipolo
Chairman of the Board of Statutory Auditors3.8yrsVeri yokVeri yok
Giannunzio Corazza
Non-Executive Directorno dataVeri yokVeri yok
Edoardo Ferragina
Non-Executive Directorno dataVeri yokVeri yok
Maurizio Altini
Independent Directorno dataVeri yokVeri yok
Giulio Centemero
Standing Auditor3.8yrsVeri yokVeri yok
Roberto Giannella
Standing Auditor3.8yrsVeri yokVeri yok

3.8yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: KIP 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.8 yıldır).